Brief: Neurotech International Signs Development Agreement For Cannabinoid Therapies
13/02/2025 01:42
Feb 13 (Reuters) - Neurotech International Ltd NTI.AX :
* NEUROTECH INTERNATIONAL LTD - NTI SIGNS DEVELOPMENT
AGREEMENT
FOR CANNABINOID THERAPIES
* NEUROTECH INTERNATIONAL - ENTERS PARTNERSHIP AGREEMENT
WITH RH
FARMA DOOEL SKOPJE
Further company coverage: NTI.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurotech International
See all newsBrief: Neurotech International Says Anthony Filippis Resigns As CEO, MD
Brief: Neurotech International Appoints Mark Davies As Executive Chairman
Brief: Neurotech International Receives Binding Commitments For Around A$4.50 Million In Placement At A$0.014 Per Share
Australia's Neurotech International slips to a month low on discounted placement
Brief: Neurotech International Requests Trading Halt